Cerenia

RSS

maropitant

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 18/08/2021

Authorisation details

Product details
Name
Cerenia
Agency product number
EMEA/V/C/000106
Active substance
maropitant citrate
International non-proprietary name (INN) or common name
maropitant
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QA04AD90
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
21
Date of issue of marketing authorisation valid throughout the European Union
28/09/2006
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

13/08/2021 Cerenia - EMEA/V/C/000106 - IB/0040

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Alimentary tract and metabolism

Therapeutic indication

Tablets

Dogs:

  • For the prevention of nausea induced by chemotherapy.
  • For the prevention of vomiting induced by motion sickness.
  • For the prevention and treatment of vomiting, in conjunction with Cerenia solution for injection and in combination with other supportive measures.

Solution for injection

Dogs:

  • For the treatment and prevention of nausea induced by chemotherapy.
  • For the prevention of vomiting except that induced by motion sickness.
  • For the treatment of vomiting, in combination with other supportive measures.
  • For the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the μ-opiate receptor agonist morphine.

Cats:

  • For the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.
  • For the treatment of vomiting, in combination with other supportive measures.

Assessment history

How useful was this page?

Add your rating
Average
3 ratings
9 ratings
2 ratings
3 ratings